Updated Jul 16, 2026
Valantine Hannah has filed 3 SEC Form 4 filings across 3 companies in the last 90 days — selling. Lifetime open-market sales: $3.17M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-24 | BBIO | BridgeBio Pharma, Inc. | S — Open-market sale | 2.2K | $68.57 | $151K |
| 2026-06-24 | BBIO | BridgeBio Pharma, Inc. | S — Open-market sale | 2.8K | $68.00 | $191K |
| 2026-06-24 | BBIO | BridgeBio Pharma, Inc. | M — Option exercise | 2.8K | $41.73 | $117K |
| 2026-06-24 | BBIO | BridgeBio Pharma, Inc. | A — Grant or award | 4.0K | $0.00 | |
| 2026-06-16 | CDNA | CareDx, Inc. | S — Open-market sale | 12.1K | $23.11 | $280K |
| 2026-06-16 | CDNA | CareDx, Inc. | A — Grant or award | 9.8K | $0.00 | |
| 2026-03-12 | BBIO | BridgeBio Pharma, Inc. | S — Open-market sale [10b5-1] | 8.7K | $72.00 | $624K |
| 2026-03-12 | BBIO | BridgeBio Pharma, Inc. | M — Option exercise [10b5-1] | 8.7K | $27.36 | $237K |
| 2026-03-03 | BBIO | BridgeBio Pharma, Inc. | S — Open-market sale [10b5-1] | 10.9K | $67.84 | $739K |
| 2026-03-03 | BBIO | BridgeBio Pharma, Inc. | S — Open-market sale [10b5-1] | 14.6K | $67.08 | $978K |
| 2026-03-03 | BBIO | BridgeBio Pharma, Inc. | M — Option exercise [10b5-1] | 25.5K | $48.45 | $1.23M |
| 2025-06-18 | CDNA | CareDx, Inc. | S — Open-market sale | 10.6K | $19.16 | $203K |
| 2025-06-13 | CDNA | CareDx, Inc. | A — Grant or award | 12.1K | $0.00 |
Valantine Hannah is a corporate insider — currently tracked as Director of BridgeBio Pharma, Inc. (BBIO). InsiderAlpha tracks every SEC Form 4 filing in real time.
3 primary Form 4 filings in the last 90 days, covering 3 companies.
Recorded transactions: 0 open-market purchases () and 7 open-market sales ($3.17M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Valantine Hannah profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.